This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberton, A. M.
Right arrow Articles by Corfield, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberton, A. M.
Right arrow Articles by Corfield, A. P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2005, p. 5504-5508, Vol. 43, No. 11
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.11.5504-5508.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

A Novel Bacterial Mucinase, Glycosulfatase, Is Associated with Bacterial Vaginosis

Anthony M. Roberton,1* Rebecca Wiggins,2 Patrick J. Horner,3,4 Rosemary Greenwood,5 Theresa Crowley,3 Arnold Fernandes,3 Monica Berry,2 and Anthony P. Corfield2

School of Biological Sciences, University of Auckland, Auckland, New Zealand,1 Mucin Research Group, Clinical Sciences South Bristol, University of Bristol, Bristol, United Kingdom,2 Milne Centre for Sexual Health, United Bristol Healthcare Trust, Bristol, United Kingdom,3 Department of Pathology and Microbiology, University of Bristol, Bristol, United Kingdom,4 Research and Development Support Unit, United Bristol Healthcare Trust, Bristol, United Kingdom5

Received 8 June 2005/ Returned for modification 1 August 2005/ Accepted 18 August 2005

The modifications to the vaginal habitat accompanying a change to vaginal flora in bacterial vaginosis (BV) are poorly understood. In this study enzymes involved in mucin degradation were measured, including a novel glycosulfatase assay. Women attending an emergency walk-in sexually transmitted disease clinic were studied. One high vaginal swab (HVS) was used to prepare a gram-stained smear to determine BV status, using Ison and Hay's criteria, and a separate swab was used for the purposes of the assays. The median glycosulfatase activity was 8.5 (range, –1.2 to 31.9) nmol h–1 1.5 ml–1 of HVS suspension in patients with BV compared to 0.5 (range, –0.7 to 9.4) nmol h–1 1.5 ml–1 of HVS suspension in patients without BV (P = <0.001). The median glycoprotein sialidase activity was 29.2 (range, –17 to 190) nmol h–1 1.5 ml–1 of HVS suspension in patients with BV compared to –1.1 (range, –41 to 48) nmol h–1 1.5 ml–1 of HVS suspension in patients without BV (P < 0.001). A rapid spot test for sialidase was positive in 22/24 patients with BV (sensitivity, 91.7%; 95% confidence interval [CI], 73 to 99%) and negative in 32/35 patients without BV (specificity, 91.4%; 95% CI, 76.9 to 98.2%) (P < 0.001). Glycosulfatase activity significantly correlated with both glycoprotein sialidase activity and the sialidase spot test (P = 0.006 and P < 0.001, respectively). The results are consistent with the hypothesis that the consortium of bacteria present in BV requires the ability to break down mucins in order to colonize the vagina and replace the normal lactobacilli.

* Corresponding author. Mailing address: School of Biological Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand. Phone: 64-9-3737599-88233. Fax: 64-9-3737416. E-mail: t.roberton{at}auckland.ac.nz.

Journal of Clinical Microbiology, November 2005, p. 5504-5508, Vol. 43, No. 11
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.11.5504-5508.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»